n an antiviral drug used against HIV; binds directly to reverse transcriptase and prevents RNA conversion to DNA; often used in combination with other drugs
Viriom Reports Clinical Efficacy Data for VM-1500, a New HIV NNRTI Dr. Vadim Bichko, Chief Scientific Officer of Viriom, presented positive interim results for a phase Ib/IIa study with VM-1500, a new HIV NNRTI , at the 15th Annual International Meeting of the Institute ...
Oct. 8, 2013 - Marketwired via Yahoo! Finance
Mark Wainberg in Los Angeles Times There are a lot of patients out there who need salvage therapy with a new NNRTI, and it looks like we'll have one,said Dr. Mark Wainberg, director of the McGill University AIDS Centre in Montreal, who was not involved in the study.